Piergiuseppe Quarato

Piergiuseppe Quarato

Auto-generated profile, based on publicly available information

Piergiuseppe Quarato

San Raffaele Telethon Institute for Gene Therapy, IRCCS San Raffaele Scientific Institute, Milan, Italy

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 February 2024 in Nature
Verified
Journal Article
Open access
PDF file
MCMartino Alfredo Cappelluti
Martino Alfredo Cappelluti
VPValeria Mollica Poeta
Valeria Mollica Poeta
SVSara Valsoni
Sara Valsoni
PQPiergiuseppe Quarato
Piergiuseppe Quarato
SMSimone Merlin
Simone Merlin
ALAngelo Lombardo
Angelo Lombardo
Permanent epigenetic silencing using programmable editors equipped with transcriptional repressors holds great promise for the treatment of human diseases1–3. However, to unlock its full therapeutic potential, an experimental confirmation of durable epigenetic silencing after the delivery of transient delivery of editors in vivo is needed. To this end, here we targeted Pcsk9, a gene expressed in hepatocytes that is involved in cholesterol homeostasis. In vitro screening of different editor designs indicated that zinc-finger proteins were the best-performing DNA-binding platform for efficient silencing of mouse Pcsk9. A single administration of lipid nanoparticles loaded with the editors’ mRNAs almost halved the circulating levels of PCSK9 for nearly one year in mice. Notably, Pcsk9 silencing and accompanying epigenetic repressive marks also persisted after forced liver regeneration, further corroborating the heritability of the newly installed epigenetic state. Improvements in construct design resulted in the development of an all-in-one configuration that we term evolved engineered transcriptional repressor (EvoETR). This design, which is characterized by a high specificity profile, further reduced the circulating levels of PCSK9 in mice with an efficiency comparable with that obtained through conventional gene editing, but without causing DNA breaks. Our study lays the foundation for the development of in vivo therapeutics that are based on epigenetic silencing.

3 February 2020 in Nature Cell Biology
Verified
Journal Article
Closed access
PDF file
GBGiorgia Barucci
Giorgia Barucci
ECEric Cornes
Eric Cornes
MSMeetali Singh
Meetali Singh
BLBlaise Li
Blaise Li
MUMartino Ugolini
Martino Ugolini
GCGermano Cecere
Germano Cecere

1 December 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
DIDafne Ibarra-Morales
Dafne Ibarra-Morales
MRMichael Rauer
Michael Rauer
PQPiergiuseppe Quarato
Piergiuseppe Quarato
LRLeily Rabbani
Leily Rabbani
FZFides Zenk
Fides Zenk
NINicola Iovino
Nicola Iovino
During embryogenesis, the genome shifts from transcriptionally quiescent to extensively active in a process known as Zygotic Genome Activation (ZGA). In Drosophila, the pioneer factor Zelda is known to be essential for the progression of development; still, it regulates the activation of only a small subset of genes at ZGA. However, thousands of genes do not require Zelda, suggesting that other mechanisms exist. By conducting GRO-seq, HiC and ChIP-seq in Drosophila embryos, we demonstrate that up to 65% of zygotically activated genes are enriched for the histone variant H2A.Z. H2A.Z enrichment precedes ZGA and RNA Polymerase II loading onto chromatin. In vivo knockdown of maternally contributed Domino, a histone chaperone and ATPase, reduces H2A.Z deposition at transcription start sites, causes global downregulation of housekeeping genes at ZGA, and compromises the establishment of the 3D chromatin structure. We infer that H2A.Z is essential for the de novo establishment of transcriptional programs during ZGA via chromatin reorganization.

4 March 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
PQPiergiuseppe Quarato
Piergiuseppe Quarato
MSMeetali Singh
Meetali Singh
ECEric Cornes
Eric Cornes
BLBlaise Li
Blaise Li
LBLoan Bourdon
Loan Bourdon
GCGermano Cecere
Germano Cecere
Inheritance and clearance of maternal mRNAs are two of the most critical events required for animal early embryonic development. However, the mechanisms regulating this process are still largely unknown. Here, we show that together with maternal mRNAs, C. elegans embryos inherit a complementary pool of small non-coding RNAs that facilitate the cleavage and removal of hundreds of maternal mRNAs. These antisense small RNAs are loaded into the maternal catalytically-active Argonaute CSR-1 and cleave complementary mRNAs no longer engaged in translation in somatic blastomeres. Induced depletion of CSR-1 specifically during embryonic development leads to embryonic lethality in a slicer-dependent manner and impairs the degradation of CSR-1 embryonic mRNA targets. Given the conservation of Argonaute catalytic activity, we propose that a similar mechanism operates to clear maternal mRNAs during the maternal-to-zygotic transition across species.

16 December 2021 in EMBO Reports
Verified
Journal Article
Open access
PDF file
MSMeetali Singh
Meetali Singh
MCMaxime Chazal
Maxime Chazal
PQPiergiuseppe Quarato
Piergiuseppe Quarato
LBLoan Bourdon
Loan Bourdon
CMChristophe Malabat
Christophe Malabat
GCGermano Cecere
Germano Cecere
SARS‐CoV‐2 infection results in impaired interferon response in patients with severe COVID‐19. However, how SARS‐CoV‐2 interferes with host immune responses is incompletely understood. Here, we sequence small RNAs from SARS‐CoV‐2‐infected human cells and identify a microRNA (miRNA) derived from a recently evolved region of the viral genome. We show that the virus‐derived miRNA produces two miRNA isoforms in infected cells by the enzyme Dicer, which are loaded into Argonaute proteins. Moreover, the predominant miRNA isoform targets the 3′UTR of interferon‐stimulated genes and represses their expression in a miRNA‐like fashion. Finally, the two viral miRNA isoforms were detected in nasopharyngeal swabs from COVID‐19 patients. We propose that SARS‐CoV‐2 can potentially employ a virus‐derived miRNA to hijack the host miRNA machinery, which could help to evade the interferon‐mediated immune response.

9 June 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
MSMeetali Singh
Meetali Singh
ECEric Cornes
Eric Cornes
BLBlaise Li
Blaise Li
PQPiergiuseppe Quarato
Piergiuseppe Quarato
LBLoan Bourdon
Loan Bourdon
GCGermano Cecere
Germano Cecere
In the Caenorhabditis elegans germline, thousands of mRNAs are concomitantly expressed with antisense 22G-RNAs, which are loaded into the Argonaute CSR-1. Despite their essential functions for animal fertility and embryonic development, how CSR-1 22G-RNAs are produced remains unknown. Here, we show that CSR-1 slicer activity is primarily involved in triggering the synthesis of small RNAs on the coding sequences of germline mRNAs and post-transcriptionally regulates a fraction of targets. CSR-1-cleaved mRNAs prime the RNA-dependent RNA polymerase, EGO-1, to synthesize 22G-RNAs in phase with translating ribosomes, in contrast to other 22G-RNAs mostly synthesized in germ granules. Moreover, codon optimality and efficient translation antagonize CSR-1 slicing and 22G-RNAs biogenesis. We propose that codon usage differences encoded into mRNA sequences might be a conserved strategy in eukaryotes to regulate small RNA biogenesis and Argonaute targeting.